Elke A. Jarboe
No Rating Available
(Learn About Our Rating System)

Elke A. Jarboe, MD

Languages spoken: English

  • Dr. Jarboe is a staff pathologist at ARUP and an associate professor of pathology at the University of Utah School of Medicine. She received her MD from and completed her anatomic pathology residency training at the University of Colorado School of Medicine. Subsequently, she completed fellowships in women’s and perinatal pathology and cytopathology at Brigham and Women's Hospital in Boston. Dr. Jarboe is a member of several professional societies, including the United States and Canadian Academy of Pathology, American Association for Cancer Research, American Society for Clinical Pathology, and College of American Pathologists.

    Dr. Jarboe's primary subspecialty and research interest is in gynecologic pathology.

    Specialties

    • Pathology, Anatomical

    Board Certification

    American Board of Pathology (Anatomic)
    American Board of Pathology (Sub: Cytopathology)
    National Board of Medical Examiners

  • Dr. Jarboe is a staff pathologist at ARUP and an associate professor of pathology at the University of Utah School of Medicine. She received her MD from and completed her anatomic pathology residency training at the University of Colorado School of Medicine. Subsequently, she completed fellowships in women’s and perinatal pathology and cytopathology at Brigham and Women's Hospital in Boston. Dr. Jarboe is a member of several professional societies, including the United States and Canadian Academy of Pathology, American Association for Cancer Research, American Society for Clinical Pathology, and College of American Pathologists.

    Dr. Jarboe's primary subspecialty and research interest is in gynecologic pathology.

    Board Certification and Academic Information

    Academic Departments Pathology -Associate Professor (Clinical)
    Academic Divisions Gynecological Oncology
    Board Certification
    American Board of Pathology (Anatomic)
    American Board of Pathology (Sub: Cytopathology)
    National Board of Medical Examiners

    Education history

    Fellowship Cytopathology - Brigham and Women's Hospital Fellow
    Fellowship Division of Women's and Perinatal Pathology - Brigham and Women's Hospital Fellow
    Residency Pathology - University of Colorado School of Medicine Resident
    Internship Pathology - University of Colorado School of Medicine Intern
    Fellowship University of Colorado School of Medicine Post-Sophomore Fellow
    Professional Medical Medicine - University of Colorado School of Medicine M.D.
    Graduate Training Microbiology - Colorado State University Master's
    Undergraduate Microbiology - Colorado State University B.S.

    Selected Publications

    Journal Article

    1. Blanchard Z, Rush CM, Arnesen S, Vahrenkamp JM, Rodriguez AC, Jarboe EA, Brown C, Chang MEK, Flory MR, Mohammed H, Modzelewska K, Lum DH, Gertz J (2022). Allele-Specific Gene Regulation, Phenotypes, and Therapeutic Vulnerabilities in Estrogen Receptor Alpha-Mutant Endometrial Cancer. Mol Cancer Res, 21(10), 1023-1036. (Read full article)
    2. Barnard ME, Meeks H, Jarboe EA, Albro J, Camp NJ, Doherty JA (2022). Familial risk of epithelial ovarian cancer after accounting for gynaecological surgery: a population-based study. J Med Genet, 60(2), 119-127. (Read full article)
    3. Harris KL, Maurer KA, Jarboe E, Werner TL, Gaffney D (2019). LVSI positive and NX in early endometrial cancer: Surgical restaging (and no further treatment if N0), or adjuvant ERT? Gynecol Oncol, 156(1), 243-250. (Read full article)
    4. Vahrenkamp JM, Szczotka K, Dodson MK, Jarboe EA, Soisson AP, Gertz J (2019). FFPEcap-seq: a method for sequencing capped RNAs in formalin-fixed paraffin-embedded samples. Genome Res, 29(11), 1826-1835. (Read full article)
    5. Dillon C, Rezvani M, McLean H, Adelman M, Dassel M, Jarboe E, Jant-Amsbury M, Payne A (2019). A tissue preparation to characterize uterine fibroid tissue properties for thermal therapies. Med Phys, 46(8), 3344-3355. (Read full article)
    6. Baniak N, Fadare O, Kbel M, DeCoteau J, Parkash V, Hecht JL, Hanley KZ, Gwin K, Zheng W, Quick CM, Jarboe EA, Liang SX, Kinloch M (2018). Targeted Molecular and Immunohistochemical Analyses of Endometrial Clear Cell Carcinoma Show that POLE Mutations and DNA Mismatch Repair Protein Deficiencies Are Uncommon. Am J Surg Pathol, 43(4), 531-537. (Read full article)
    7. Fadare O, Desouki MM, Gwin K, Hanley KZ, Jarboe EA, Liang SX, Quick CM, Rawish KR, Roma AA, Zheng W, Hecht JL, Parkash V, Osunkoya AO (2017). Clear Cell Renal Cell Carcinoma Metastatic to the Gynecologic Tract: A Clinicopathologic Analysis of 17 Cases. Int J Gynecol Pathol, 37(6), 525-535. (Read full article)
    8. Vahrenkamp JM, Yang CH, Rodriguez AC, Almomen A, Berrett KC, Trujillo AN, Guillen KP, Welm BE, Jarboe EA, Janat-Amsbury MM, Gertz J (2017). Clinical and Genomic Crosstalk between Glucocorticoid Receptor and Estrogen Receptor α In Endometrial Cancer. Cell Rep, 22(11), 2995-3005. (Read full article)
    9. Taurin S, Yang CH, Reyes M, Cho S, Coombs DM, Jarboe EA, Werner TL, Peterson CM, Jant-Amsbury MM (2017). Endometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model. Int J Gynecol Cancer, 28(1), 152-160. (Read full article)
    10. Longacre TA, Broaddus R, Chuang LT, Cohen MB, Jarboe EA, Mutter GL, Otis CN, Zaino RJ, Members of the Cancer Biomarker Reporting Committee College of American Pathologists (2017). Template for Reporting Results of Biomarker Testing of Specimens From Patients With Carcinoma of the Endometrium. Arch Pathol Lab Med, 141(11), 1508-1512. (Read full article)
    11. Shen Z, Kang J, Shakya A, Tabaka M, Jarboe EA, Regev A, Tantin D (2017). Enforcement of developmental lineage specificity by transcription factor Oct1. Elife, 6. (Read full article)
    12. Almomen A, Jarboe EA, Dodson MK, Peterson CM, Owen SC, Jant-Amsbury MM (2016). Imiquimod Induces Apoptosis in Human Endometrial Cancer Cells In vitro and Prevents Tumor Progression In vivo. Pharm Res, 33(9), 2209-17. (Read full article)
    13. Cho S, Park H, Jarboe EA, Peterson CM, Bae YH, Jant-Amsbury MM (2015). Design and Characterization of Bioengineered Cancer-Like Stem Cells. PLoS One, 10(10), e0141172. (Read full article)
    14. Fata CR, Seeley EH, Desouki MM, Du L, Gwin K, Hanley KZ, Hecht JL, Jarboe EA, Liang SX, Parkash V, Quick CM, Zheng W, Shyr Y, Caprioli RM, Fadare O (2015). Are clear cell carcinomas of the ovary and endometrium phenotypically identical? A proteomic analysis. Hum Pathol, 46(10), 1427-36. (Read full article)
    15. Almomen A, Cho S, Yang CH, Li Z, Jarboe EA, Peterson CM, Huh KM, Jant-Amsbury MM (2015). Thermosensitive progesterone hydrogel: a safe and effective new formulation for vaginal application. Pharm Res, 32(7), 2266-79. (Read full article)
    16. Yang CH, Almomen A, Wee YS, Jarboe EA, Peterson CM, Jant-Amsbury MM (2015). An estrogen-induced endometrial hyperplasia mouse model recapitulating human disease progression and genetic aberrations. Cancer Med, 4(7), 1039-50. (Read full article)
    17. Fadare O, Desouki MM, Gwin K, Hanley KZ, Jarboe EA, Liang SX, Quick CM, Zheng W, Parkash V, Hecht JL (2013). Frequent expression of napsin A in clear cell carcinoma of the endometrium: potential diagnostic utility. Am J Surg Pathol, 38(2), 189-96. (Read full article)
    18. Jarboe EA, Hirschowitz SL, Geiersbach KB, Wallander ML, Tripp SR, Layfield LJ (2013). Juvenile granulosa cell tumors: immunoreactivity for CD99 and Fli-1 and EWSR1 translocation status: a study of 11 cases. Int J Gynecol Pathol, 33(1), 11-5. (Read full article)
    19. Cho S, Sun Y, Jarboe EA, Soisson AP, Dodson MK, Gaffney DK, Peterson CM, Jant-Amsbury MM (2013). Mucoadhesive hybrid gel improves intraperitoneal platinum delivery. Int J Pharm, 458(1), 148-55. (Read full article)
    20. Cho S, Sun Y, Soisson AP, Dodson MK, Peterson CM, Jarboe EA, Kennedy AM, Jant-Amsbury MM (2013). Characterization and evaluation of pre-clinical suitability of a syngeneic orthotopic mouse ovarian cancer model. Anticancer Res, 33(4), 1317-24. (Read full article)
    21. Furtado LV, Paxton CN, Jama MA, Tripp SR, Wilson AR, Lyon E, Jarboe EA, Thaker HM, Geiersbach KB (2013). Diagnostic utility of microsatellite genotyping for molar pregnancy testing. Arch Pathol Lab Med, 137(1), 55-63. (Read full article)
    22. Folkins AK, Jarboe EA, Saleemuddin A, Lee Y, Callahan MJ, Drapkin R, Garber JE, Muto MG, Tworoger S, Crum CP (2008). A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations. Gynecol Oncol, 109(2), 168-73. (Read full article)
    23. Jarboe EA, Folkins AK, Nucci MR, Kindelberger D, Drapkin R, Miron A, Lee Y, Crum CP (2008). Serous Carcinogenesis in the Fallopian Tube (SCAT): A Descriptive Classification. Int J Gynecol Pathol, 27(1), 1-9.
    24. Jarboe EA, Thompson LC, Heinz D, McGregor JA, Shroyer KR (2004). Telomerase and human papillomavirus as diagnostic adjuncts for cervical dysplasia and carcinoma. Hum Pathol, 35(4), 396-402. (Read full article)

    Review

    1. Salah HT, Stivers NS, Jarboe EA, Dodson MK, Ward MB (2020). Extraskeletal Myxoid Chondrosarcoma of the Vulva Confirmed by EWSR1 FISH: A Case Report and Review of the Literature. [Review]. Int J Gynecol Pathol, 40(5), 470-476. (Read full article)
    2. Williams NL, Werner TL, Jarboe EA, Gaffney DK (2015). Adenocarcinoma of the cervix: should we treat it differently? [Review]. Curr Oncol Rep, 17(4), 17. (Read full article)
    3. Shaaban AM, Rezvani M, Elsayes KM, Baskin H Jr, Mourad A, Foster BR, Jarboe EA, Menias CO (2014). Ovarian malignant germ cell tumors: cellular classification and clinical and imaging features. [Review]. Radiographics, 34(3), 777-801. (Read full article)
    4. Jarboe EA, Folkins AK, Drapkin R, Ince TA, Agoston ES, Crum CP (2008). Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective. [Review]. Histopathology, 53(2), 127-38. (Read full article)

    Book Chapter

    1. Jarboe EA, Folkins A, Callahan MJ, Crum CP (2008). Pathology of BRCA-Associated Ovarian Cancers, Including Occult Cancers. In Lu KH (Ed.), Hereditary Gynecologic Cancer: Risk, Prevention, and Management (pp. 29-44). Informa Healthcare.

    Letter

    1. Fadare O, Roma AA, Desouki MM, Gwin K, Hanley KZ, Jarboe EA, Liang SX, Quick CM, Zheng W, Hecht JL, Parkash V, Wang XJ (2017). The significance of L1CAM expression in clear cell carcinoma of the endometrium. [Letter to the editor]. Histopathology, 72(3), 532-538. (Read full article)